HomeBWAY • NASDAQ
add
Brainsway Ltd - ADR
Previous close
$13.74
Day range
$13.66 - $14.40
Year range
$3.92 - $14.65
Market cap
525.84M USD
Avg Volume
189.28K
P/E ratio
1.90
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 14.54M | 27.43% |
Operating expense | 9.20M | 13.89% |
Net income | 2.93M | 89.47% |
Net profit margin | 20.16 | 48.67% |
Earnings per share | 0.06 | 219.20% |
EBITDA | 2.27M | 245.73% |
Effective tax rate | -15.43% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 67.70M | -2.37% |
Total assets | 112.92M | 19.72% |
Total liabilities | 39.70M | 24.04% |
Total equity | 73.22M | — |
Shares outstanding | 36.66M | — |
Price to book | 6.87 | — |
Return on assets | 4.24% | — |
Return on capital | 6.11% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 2.93M | 89.47% |
Cash from operations | -759.00K | -121.72% |
Cash from investing | -1.03M | 43.95% |
Cash from financing | -987.00K | -105.04% |
Net change in cash | -2.76M | -113.00% |
Free cash flow | -7.01M | -731.76% |
About
BrainsWay Ltd. is an international company that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a non-invasive treatment for depression, OCD, and smoking addiction. The company was founded in 2003 and has offices in the US and Jerusalem. Wikipedia
Founded
2003
Headquarters
Website
Employees
120